2022-10-01 2023-09-30 false Capium Accounts Production 1.1 12641579 bus:AbridgedAccounts 2022-10-01 2023-09-30 12641579 bus:FRS102 2022-10-01 2023-09-30 12641579 bus:AuditExemptWithAccountantsReport 2022-10-01 2023-09-30 12641579 bus:SmallCompaniesRegimeForAccounts 2022-10-01 2023-09-30 12641579 bus:PrivateLimitedCompanyLtd 2022-10-01 2023-09-30 12641579 2022-10-01 2023-09-30 12641579 2023-09-30 12641579 bus:RegisteredOffice 2022-10-01 2023-09-30 12641579 core:WithinOneYear 2023-09-30 12641579 core:AfterOneYear 2023-09-30 12641579 bus:Director1 2022-10-01 2023-09-30 12641579 bus:Director1 2023-09-30 12641579 bus:Director1 2021-10-01 2022-09-30 12641579 2021-10-01 12641579 bus:LeadAgentIfApplicable 2022-10-01 2023-09-30 12641579 2021-10-01 2022-09-30 12641579 2022-09-30 12641579 core:WithinOneYear 2022-09-30 12641579 core:AfterOneYear 2022-09-30 12641579 bus:EntityAccountantsOrAuditors 2021-10-01 2022-09-30 12641579 core:LandBuildings 2022-10-01 2023-09-30 12641579 core:LandBuildings 2023-09-30 12641579 core:LandBuildings 2022-09-30 12641579 core:PlantMachinery 2022-10-01 2023-09-30 12641579 core:PlantMachinery 2023-09-30 12641579 core:PlantMachinery 2022-09-30 12641579 core:FurnitureFittings 2022-10-01 2023-09-30 12641579 core:FurnitureFittings 2023-09-30 12641579 core:FurnitureFittings 2022-09-30 12641579 core:ComputerEquipment 2022-10-01 2023-09-30 12641579 core:ComputerEquipment 2023-09-30 12641579 core:ComputerEquipment 2022-09-30 12641579 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-09-30 12641579 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2022-09-30 12641579 core:CostValuation core:Non-currentFinancialInstruments 2023-09-30 12641579 core:CostValuation core:Non-currentFinancialInstruments 2022-09-30 12641579 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2023-09-30 12641579 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2023-09-30 12641579 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2023-09-30 12641579 core:Non-currentFinancialInstruments 2023-09-30 12641579 core:Non-currentFinancialInstruments 2022-09-30 12641579 core:ShareCapital 2023-09-30 12641579 core:ShareCapital 2022-09-30 12641579 core:RetainedEarningsAccumulatedLosses 2023-09-30 12641579 core:RetainedEarningsAccumulatedLosses 2022-09-30 12641579 dpl:Item1 2022-10-01 12641579 dpl:Item1 2023-09-30 12641579 dpl:Item1 2021-10-01 12641579 dpl:Item1 2022-09-30 iso4217:GBP xbrli:shares xbrli:pure
Logo On Report
Registered Number: 12641579
England and Wales

 

 

 

PRIMROSE COURT HEALTH CARE LIMITED


Abridged Accounts
 


Period of accounts

Start date: 01 October 2022

End date: 30 September 2023
Chartered Management Accountants' report to the board of directors on the preparation of the unaudited statutory accounts Primrose Court Health Care Limited for the year ended 30 September 2023

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Primrose Court Health Care Limited for the year ended 30 September 2023 which comprise of the Profit and Loss Account, the Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Chartered Institute of Management Accountants, we are subject to its ethical and other professional requirements which are detailed at http://www.cimaglobal.com.

This report is made solely to the Board of Directors of Primrose Court Health Care Limited , as a body, in accordance with the terms of our engagement letter dated 19 August 2024. Our work has been undertaken solely to prepare for your approval the accounts of Primrose Court Health Care Limited and state those matters that we have agreed to state to the Board of Directors of Primrose Court Health Care Limited, as a body, in this report in accordance with the requirements of the Chartered Institute of Management Accountants as detailed at http://www.cimaglobal.com. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Primrose Court Health Care Limited and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Primrose Court Health Care Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit Primrose Court Health Care Limited. You consider that Primrose Court Health Care Limited is exempt from the statutory audit requirement for the year

We have not been instructed to carry out an audit or a review of the accounts of Primrose Court Health Care Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.



....................................................
T & K Accounting Group
69 Banstead Road
Carshalton
SM5 3NP
19 August 2024
1
 
 
Notes
 
2023
£
  2022
£
Fixed assets      
Tangible fixed assets 3 246,731    249,528 
246,731    249,528 
Current assets      
Debtors 2,850    2,850 
Cash at bank and in hand 66    1,799 
2,916    4,649 
Creditors: amount falling due within one year (279,709)   (263,915)
Net current assets (276,793)   (259,266)
 
Total assets less current liabilities (30,062)   (9,738)
Creditors: amount falling due after more than one year (82,809)   (105,385)
Net assets (112,871)   (115,123)
 

Capital and reserves
     
Called up share capital 1    1 
Profit and loss account (112,874)   (115,125)
Shareholders' funds (112,873)   (115,124)
 


For the year ended 30 September 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 19 August 2024 and were signed by:


-------------------------------
Alsahar Noohukannu
Director
2
General Information
Primrose Court Health Care Limited is a private company, limited by shares, registered in England and Wales, registration number 12641579, registration address 219 BRIGHTON ROAD, PURLEY SURREY, CR8 4HF.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Government grants
Government grants received are credited to deferred income. Grants towards capital expenditure are released to the income statement over the expected useful life of the assets. Grants received towards revenue expenditure are released to the income statement as the related expenditure is incurred.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. The company has decided not to charge depreciation for Land & building effective from financial year 2022/23. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Land and Buildings 0 Straight Line
Plant and Machinery 25 Reducing Balance
Fixtures and Fittings 25 Reducing Balance
Computer Equipment 25 Reducing Balance
2.

Average number of employees


Average number of employees during the year was 26 (2022 : 24).
3.

Tangible fixed assets

Cost or valuation Land and Buildings   Plant and Machinery   Fixtures and Fittings   Computer Equipment   Total
  £   £   £   £   £
At 01 October 2022 300,627    601    9,341    3,630    314,199 
Additions        
Disposals        
At 30 September 2023 300,627    601    9,341    3,630    314,199 
Depreciation
At 01 October 2022 60,125    235    3,310    999    64,669 
Charge for year   122    1,945    732    2,799 
On disposals        
At 30 September 2023 60,125    357    5,255    1,731    67,468 
Net book values
Closing balance as at 30 September 2023 240,502    244    4,086    1,899    246,731 
Opening balance as at 01 October 2022 240,501    366    6,030    2,631    249,528 


4.

Related parties

During the year the company entered into the following transactions with related parties:
Transaction value - income/(expenses) Balance owed by/(owed to)
2023
£
 2022
£
 2023
£
 2022
£
Wentworth Rest home Limited1,080 8,353 (257,001)(258,081)

Included within amounts Owed to Group Undertakings due to Wentworth Rest home, a company in which the director of primrose court health care Limited is a director.
3